Calling Dr. Salesforce, Dr. Salesforce stat…

Verticals onDemand, a provider of industry-specific on-demand CRM solutions via Salesforce.com, announced today that its first product suite – known as VbioPharma – will be tailored for biotechnology and pharmaceutical companies.

Verticals onDemand co-chairman Mark Armenante, a long-time veteran of the industry, is quite enthusiastic today, saying “With both traditional industry players being recently acquired and the world moving quickly to the onDemand model, the opportunity has never been so great to rapidly create the next CRM industry standard.”

VBioPharma is being plugged as the “first integrated suite of sales, marketing, and service applications for global biotechnology and pharmaceutical companies delivered through an on-demand platform.”

Primary features in VbioPharma include selling functionality for managed-care, specialty-care, and primary-care salesforces; call reporting, PDMA-compliant sampling, and signature capture on mobile phones and tablet PCs; aggregate spend, expense capture, and state compliance reporting; closed loop marketing and campaign management; medical information request and patient reimbursement support; and home office analytics.

VBioPharma is priced on a per user per month basis, though no specifics were offered in the announcement. General availability is planned for the second quarter of 2007.